{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:55:30Z","timestamp":1793976930677,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700268"],"award-info":[{"award-number":["81700268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1605226"],"award-info":[{"award-number":["U1605226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant from Central Government for Local Development of Science and Technology of Sichuan Province of China","award":["2020ZYD047"],"award-info":[{"award-number":["2020ZYD047"]}]},{"name":"Grant from Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province of China","award":["xtcx2019-15"],"award-info":[{"award-number":["xtcx2019-15"]}]},{"name":"Luzhou-Southwest Medical University joint scientific funding of China","award":["2018LZXNYD-ZK25"],"award-info":[{"award-number":["2018LZXNYD-ZK25"]}]},{"name":"Special Supporting Foundation for Young Scientists of Southwest Medical University of China","award":["2021-2023"],"award-info":[{"award-number":["2021-2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Exosomes of human cardiosphere-derived cells (CDCs) are very promising for treating cardiovascular disorders. However, the current challenge is inconvenient delivery methods of exosomes for clinical application. The present study aims to explore the potential to enhance the therapeutic effect of exosome (EXO) from human CDCs to myocardial hypertrophy. A heart homing peptide (HHP) was displayed on the surface of exosomes derived from CDCs that were forced to express the HHP fused on the N-terminus of the lysosomal-associated membrane protein 2b (LAMP2b). The cardiomyocyte-targeting capability of exosomes were analyzed and their therapeutic effects were evaluated in a mouse model of myocardial hypertrophy induced by transverse aorta constriction (TAC). The molecular mechanisms of the therapeutic effects were dissected in angiotensin II-induced neonatal rat cardiomyocyte (NRCMs) hypertrophy model using a combination of biochemistry, immunohistochemistry and molecular biology techniques. We found that HHP-exosomes (HHP-EXO) accumulated more in mouse hearts after intravenous delivery and in cultured NRCMs than control exosomes (CON-EXO). Cardiac function of TAC mice was significantly improved with intravenous HHP-EXO administration. Left ventricular hypertrophy was reduced more by HHP-EXO than CON-EXO via inhibition of \u03b2-MHC, BNP, GP130, p-STAT3, p-ERK1\/2, and p-AKT. Similar results were obtained in angiotensin II-induced hypertrophy of NRCMs, in which the beneficial effects of HHP-EXO were abolished by miRNA-148a inhibition. Our results indicate that HHP-EXO preferentially target the heart and improve the therapeutic effect of CDCs-exosomes on cardiac hypertrophy. The beneficial therapeutic effect is most likely attributed to miRNA-148a-mediated suppression of GP130, which in turn inhibits STAT3\/ERK1\/2\/AKT signaling pathway, leading to improved cardiac function and remodeling.<\/jats:p>","DOI":"10.1186\/s12951-022-01630-3","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T06:02:39Z","timestamp":1664863359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy"],"prefix":"10.1186","volume":"20","author":[{"given":"Liang","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xiang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xitong","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"1630_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245\u201362.","journal-title":"J Mol Cell Cardiol"},{"key":"1630_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487\u2013514.","journal-title":"Annu Rev Biochem"},{"key":"1630_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12967-020-02622-3","volume":"18","author":"S Nikfarjam","year":"2020","unstructured":"Nikfarjam S, Rezaie J, Zolbanin NM, Jafari R. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Transl Med. 2020;18:449.","journal-title":"J Transl Med"},{"key":"1630_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1586\/erc.12.102","volume":"10","author":"M Kreke","year":"2012","unstructured":"Kreke M, Smith RR, Marban L, Marban E. Cardiospheres and cardiosphere-derived cells as therapeutic agents following myocardial infarction. Expert Rev Cardiovasc Ther. 2012;10:1185\u201394.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1630_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3727\/096368911X627381","volume":"21","author":"K Cheng","year":"2012","unstructured":"Cheng K, Malliaras K, Li TS, Sun B, Houde C, Galang G, Smith J, Matsushita N, Marban E. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia\/reperfusion. Cell Transplant. 2012;21:1121\u201335.","journal-title":"Cell Transplant"},{"key":"1630_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AGE Ibrahim","year":"2014","unstructured":"Ibrahim AGE, Cheng K, Marban E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. 2014;2:606\u201319.","journal-title":"Stem Cell Reports"},{"key":"1630_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/HYPERTENSIONAHA.118.11239","volume":"72","author":"L Cambier","year":"2018","unstructured":"Cambier L, Giani JF, Liu W, Ijichi T, Echavez AK, Valle J, Marban E. Angiotensin II-induced end-organ damage in mice is attenuated by human exosomes and by an exosomal Y RNA fragment. Hypertension. 2018;72:370\u201380.","journal-title":"Hypertension"},{"key":"1630_CR8","first-page":"201","volume":"38","author":"R Gallet","year":"2017","unstructured":"Gallet R, Dawkins J, Valle J, Simsolo E, de Couto G, Middleton R, Tseliou E, Luthringer D, Kreke M, Smith RR, et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J. 2017;38:201\u201311.","journal-title":"Eur Heart J"},{"key":"1630_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7150\/thno.38198","volume":"10","author":"Z Wan","year":"2020","unstructured":"Wan Z, Zhao L, Lu F, Gao X, Dong Y, Zhao Y, Wei M, Yang G, Xing C, Liu L. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics. 2020;10:218\u201330.","journal-title":"Theranostics"},{"key":"1630_CR10","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.7150\/thno.51571","volume":"11","author":"P Chen","year":"2021","unstructured":"Chen P, Wang L, Fan X, Ning X, Yu B, Ou C, Chen M. Targeted delivery of extracellular vesicles in heart injury. Theranostics. 2021;11:2263\u201377.","journal-title":"Theranostics"},{"key":"1630_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, Lee JJ, Kalluri R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498\u2013503.","journal-title":"Nature"},{"key":"1630_CR12","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3390\/cells9102191","volume":"9","author":"XTT Dang","year":"2020","unstructured":"Dang XTT, Kavishka JM, Zhang DX, Pirisinu M, Le MTN. Extracellular vesicles as an efficient and versatile system for drug delivery. Cells. 2020;9:2191.","journal-title":"Cells"},{"issue":"10","key":"1630_CR13","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/1061186X.2021.1929257","volume":"29","author":"Y Yu","year":"2021","unstructured":"Yu Y, Li W, Mao L, Peng W, Long D, Li D, Zhou R, Dang X. Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer\u2019s disease. J Drug Target. 2021;29(10):1128\u201338.","journal-title":"J Drug Target"},{"key":"1630_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.gene.2015.08.067","volume":"575","author":"D Xitong","year":"2016","unstructured":"Xitong D, Xiaorong Z. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases. Gene. 2016;575:377\u201384.","journal-title":"Gene"},{"key":"1630_CR15","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.104.529537","volume":"112","author":"L Zhang","year":"2005","unstructured":"Zhang L, Hoffman JA, Ruoslahti E. Molecular profiling of heart endothelial cells. Circulation. 2005;112:1601\u201311.","journal-title":"Circulation"},{"key":"1630_CR16","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.7150\/thno.20524","volume":"8","author":"A Vandergriff","year":"2018","unstructured":"Vandergriff A, Huang K, Shen D, Hu S, Hensley MT, Caranasos TG, Qian L, Cheng K. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics. 2018;8:1869\u201378.","journal-title":"Theranostics"},{"key":"1630_CR17","doi-asserted-by":"publisher","first-page":"10041","DOI":"10.1038\/s41598-019-46407-1","volume":"9","author":"KI Mentkowski","year":"2019","unstructured":"Mentkowski KI, Lang JK. Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Sci Rep. 2019;9:10041.","journal-title":"Sci Rep"},{"key":"1630_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jconrel.2014.12.013","volume":"199","author":"T Smyth","year":"2015","unstructured":"Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015;199:145\u201355.","journal-title":"J Control Release"},{"key":"1630_CR19","doi-asserted-by":"publisher","first-page":"26316","DOI":"10.3402\/jev.v4.26316","volume":"4","author":"OP Wiklander","year":"2015","unstructured":"Wiklander OP, Nordin JZ, O\u2019Loughlin A, Gustafsson Y, Corso G, Mager I, Vader P, Lee Y, Sork H, Seow Y, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316.","journal-title":"J Extracell Vesicles"},{"key":"1630_CR20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/ajh\/hpy123","volume":"31","author":"P Blanch","year":"2018","unstructured":"Blanch P, Armario P, Oliveras A, Fernandez-Llama P, Vazquez S, Pareja J, Alvarez E, Calero F, Sierra C, de la Sierra A. Association of either left ventricular hypertrophy or diastolic dysfunction with 24-hour central and peripheral blood pressure. Am J Hypertens. 2018;31:1293\u20139.","journal-title":"Am J Hypertens"},{"key":"1630_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fphys.2020.00625","volume":"11","author":"W Yan","year":"2020","unstructured":"Yan W, Dong ZC, Wang JJ, Zhang YL, Wang HX, Zhang B, Li HH. Deficiency of the immunoproteasome LMP10 subunit attenuates angiotensin II-induced cardiac hypertrophic remodeling via autophagic degradation of gp130 and IGF1R. Front Physiol. 2020;11:625.","journal-title":"Front Physiol"},{"key":"1630_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.stemcr.2018.01.023","volume":"10","author":"MA Aminzadeh","year":"2018","unstructured":"Aminzadeh MA, Rogers RG, Fournier M, Tobin RE, Guan X, Childers MK, Andres AM, Taylor DJ, Ibrahim A, Ding X, et al. Exosome-mediated benefits of cell therapy in mouse and human models of duchenne muscular dystrophy. Stem Cell Reports. 2018;10:942\u201355.","journal-title":"Stem Cell Reports"},{"key":"1630_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ymthe.2018.11.011","volume":"27","author":"A Raso","year":"2019","unstructured":"Raso A, Dirkx E, Philippen LE, Fernandez-Celis A, De Majo F, Sampaio-Pinto V, Sansonetti M, Juni R, El Azzouzi H, Calore M, et al. Therapeutic delivery of miR-148a suppresses ventricular dilation in heart failure. Mol Ther. 2019;27:584\u201399.","journal-title":"Mol Ther"},{"key":"1630_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/cvr\/cvu167","volume":"103","author":"L Barile","year":"2014","unstructured":"Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu LM, Torre T, Siclari F, Moccetti T, Vassalli G. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014;103:530\u201341.","journal-title":"Cardiovasc Res"},{"key":"1630_CR25","doi-asserted-by":"publisher","first-page":"11665","DOI":"10.1074\/jbc.RA119.007537","volume":"294","author":"S Eguchi","year":"2019","unstructured":"Eguchi S, Takefuji M, Sakaguchi T, Ishihama S, Mori Y, Tsuda T, Takikawa T, Yoshida T, Ohashi K, Shimizu Y, et al. Cardiomyocytes capture stem cell-derived, anti-apoptotic microRNA-214 via clathrin-mediated endocytosis in acute myocardial infarction. J Biol Chem. 2019;294:11665\u201374.","journal-title":"J Biol Chem"},{"key":"1630_CR26","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1002\/jcb.26621","volume":"119","author":"H Namazi","year":"2018","unstructured":"Namazi H, Mohit E, Namazi I, Rajabi S, Samadian A, Hajizadeh-Saffar E, Aghdami N, Baharvand H. Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA. J Cell Biochem. 2018;119:4150\u201360.","journal-title":"J Cell Biochem"},{"key":"1630_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/NPM-200477","volume":"13","author":"JJ Volpe","year":"2020","unstructured":"Volpe JJ. Commentary - exosomes: realization of the great therapeutic potential of stem cells. J Neonatal Perinatal Med. 2020;13:287\u201391.","journal-title":"J Neonatal Perinatal Med"},{"key":"1630_CR28","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.hrthm.2012.07.012","volume":"9","author":"E Marban","year":"2012","unstructured":"Marban E, Cingolani E. Heart to heart: cardiospheres for myocardial regeneration. Heart Rhythm. 2012;9:1727\u201331.","journal-title":"Heart Rhythm"},{"key":"1630_CR29","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","volume":"120","author":"PV Johnston","year":"2009","unstructured":"Johnston PV, Sasano T, Mills K, Evers R, Lee ST, Smith RR, Lardo AC, Lai S, Steenbergen C, Gerstenblith G, et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2009;120:1075\u201383.","journal-title":"Circulation"},{"key":"1630_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jacc.2010.07.049","volume":"57","author":"ST Lee","year":"2011","unstructured":"Lee ST, White AJ, Matsushita S, Malliaras K, Steenbergen C, Zhang Y, Li TS, Terrovitis J, Yee K, Simsir S, et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol. 2011;57:455\u201365.","journal-title":"J Am Coll Cardiol"},{"key":"1630_CR31","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","volume":"379","author":"RR Makkar","year":"2012","unstructured":"Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marban L, Mendizabal A, Johnston PV, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379:895\u2013904.","journal-title":"Lancet"},{"issue":"4","key":"1630_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/pharmaceutics10040218","volume":"10","author":"SG Antimisiaris","year":"2018","unstructured":"Antimisiaris SG, Mourtas S, Marazioti A. Exosomes and exosome-inspired vesicles for targeted drug delivery. Pharmaceutics. 2018;10(4):218.","journal-title":"Pharmaceutics"},{"key":"1630_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jbiotec.2013.03.013","volume":"165","author":"Y Takahashi","year":"2013","unstructured":"Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T, Takakura Y. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013;165:77\u201384.","journal-title":"J Biotechnol"},{"key":"1630_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","volume":"224","author":"SAA Kooijmans","year":"2016","unstructured":"Kooijmans SAA, Fliervoet LAL, van der Meel R, Fens MHAM, Heijnen HFG, van Bergen EnHenegouwen PMP, Vader P, Schiffelers RM. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release. 2016;224:77\u201385.","journal-title":"J Control Release"},{"key":"1630_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.vph.2015.02.008","volume":"71","author":"C Emanueli","year":"2015","unstructured":"Emanueli C, Shearn AI, Angelini GD, Sahoo S. Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vascul Pharmacol. 2015;71:24\u201330.","journal-title":"Vascul Pharmacol"},{"issue":"2","key":"1630_CR36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.116.024590","volume":"136","author":"G de Couto","year":"2017","unstructured":"de Couto G, Gallet R, Cambier L, Jaghatspanyan E, Makkar N, Dawkins JF, Berman BP, Marban E. Exosomal MicroRNA transfer into macrophages mediates cellular postconditioning. Circulation. 2017;136(2):200\u201314.","journal-title":"Circulation"},{"issue":"573","key":"1630_CR37","doi-asserted-by":"publisher","first-page":"eabb3336","DOI":"10.1126\/scitranslmed.abb3336","volume":"12","author":"K Hirai","year":"2020","unstructured":"Hirai K, Ousaka D, Fukushima Y, Kondo M, Eitoku T, Shigemitsu Y, Hara M, Baba K, Iwasaki T, Kasahara S, et al. Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy. Sci Transl Med. 2020;12(573):eabb3336.","journal-title":"Sci Transl Med"},{"key":"1630_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1189\/jlb.0410217","volume":"88","author":"JS Silver","year":"2010","unstructured":"Silver JS, Hunter CA. gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol. 2010;88:1145\u201356.","journal-title":"J Leukoc Biol"},{"key":"1630_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","volume":"31","author":"T Tsutamoto","year":"1998","unstructured":"Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:391\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1630_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1359-6101(98)80005-1","volume":"8","author":"T Hirano","year":"1997","unstructured":"Hirano T, Nakajima K, Hibi M. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 1997;8:241\u201352.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"Suppl 1","key":"1630_CR41","doi-asserted-by":"publisher","first-page":"S414","DOI":"10.1038\/bjp.2008.1","volume":"153","author":"P Fischer","year":"2008","unstructured":"Fischer P, Hilfiker-Kleiner D. Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br J Pharmacol. 2008;153(Suppl 1):S414-427.","journal-title":"Br J Pharmacol"},{"key":"1630_CR42","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1074\/jbc.M111.246173","volume":"287","author":"SA Mir","year":"2012","unstructured":"Mir SA, Chatterjee A, Mitra A, Pathak K, Mahata SK, Sarkar S. Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J Biol Chem. 2012;287:2666\u201377.","journal-title":"J Biol Chem"},{"key":"1630_CR43","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","volume":"126","author":"S Ye","year":"2020","unstructured":"Ye S, Luo W, Khan ZA, Wu G, Xuan L, Shan P, Lin K, Chen T, Wang J, Hu X, et al. Celastrol attenuates angiotensin II-induced cardiac remodeling by targeting STAT3. Circ Res. 2020;126:1007\u201323.","journal-title":"Circ Res"},{"key":"1630_CR44","doi-asserted-by":"publisher","first-page":"H2797","DOI":"10.1152\/ajpheart.2000.279.6.H2797","volume":"279","author":"WS Akers","year":"2000","unstructured":"Akers WS, Cross A, Speth R, Dwoskin LP, Cassis LA. Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy. Am J Physiol Heart Circ Physiol. 2000;279:H2797-2806.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1630_CR45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/ATVBAHA.118.312158","volume":"39","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Peters AM, Wang S, Janda A, Chen J, Zhou P, Arthur E, Kwartler CS, Milewicz DM. Reversal of aortic enlargement induced by increased biomechanical forces requires AT1R inhibition in conjunction with AT2R activation. Arterioscler Thromb Vasc Biol. 2019;39:459\u201366.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1630_CR46","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/nprot.2012.131","volume":"7","author":"S El-Andaloussi","year":"2012","unstructured":"El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C, Alvarez-Erviti L, Sargent IL, Wood MJ. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc. 2012;7:2112\u201326.","journal-title":"Nat Protoc"},{"key":"1630_CR47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","volume":"115","author":"RR Smith","year":"2007","unstructured":"Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, Marban E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115:896\u2013908.","journal-title":"Circulation"},{"key":"1630_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41417-018-0032-3","volume":"25","author":"L Mao","year":"2018","unstructured":"Mao L, Li X, Gong S, Yuan H, Jiang Y, Huang W, Sun X, Dang X. Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis. Cancer Gene Ther. 2018;25:248\u201359.","journal-title":"Cancer Gene Ther"},{"key":"1630_CR49","doi-asserted-by":"publisher","first-page":"12141","DOI":"10.1111\/jcmm.15859","volume":"24","author":"WY Wu","year":"2020","unstructured":"Wu WY, Cui YK, Hong YX, Li YD, Wu Y, Li G, Li GR, Wang Y. Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1-mediated activation of AMPK\/Nrf2 signal molecules. J Cell Mol Med. 2020;24:12141\u201353.","journal-title":"J Cell Mol Med"},{"key":"1630_CR50","doi-asserted-by":"crossref","unstructured":"Tavakoli R, Nemska S, Jamshidi P, Gassmann M, Frossard N. Technique of minimally invasive transverse aortic constriction in mice for induction of left ventricular hypertrophy. J Vis Exp. 2017;(127):e56231.","DOI":"10.3791\/56231"},{"key":"1630_CR51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/9780470942390.mo100149","volume":"1","author":"X Zhao","year":"2011","unstructured":"Zhao X, Ho D, Gao S, Hong C, Vatner DE, Vatner SF. Arterial pressure monitoring in mice. Curr Protoc Mouse Biol. 2011;1:105\u201322.","journal-title":"Curr Protoc Mouse Biol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01630-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01630-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01630-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T11:43:43Z","timestamp":1701171823000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01630-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1630"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01630-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"assertion":[{"value":"31 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human specimens were in accordance with the ethical standards of Xiamen University and with the 1964 Helsinki declaration. An informed consent was obtained from each participant prior to the relevant surgery. All animal study protocols were approved by the ethical committee of Xiamen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}